Two Sigma Advisers LP reduced its stake in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP - Free Report) by 13.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 369,476 shares of the company's stock after selling 56,100 shares during the quarter. Two Sigma Advisers LP owned 1.00% of Crescent Capital BDC worth $7,101,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of CCAP. Montag A & Associates Inc. purchased a new stake in shares of Crescent Capital BDC in the fourth quarter valued at approximately $35,000. C M Bidwell & Associates Ltd. purchased a new position in shares of Crescent Capital BDC during the 4th quarter worth $39,000. Aquatic Capital Management LLC purchased a new position in shares of Crescent Capital BDC during the 4th quarter worth $129,000. Generation Capital Management LLC purchased a new position in shares of Crescent Capital BDC during the 4th quarter worth $192,000. Finally, Dynamic Technology Lab Private Ltd acquired a new position in Crescent Capital BDC during the 4th quarter worth about $218,000. 49.46% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
CCAP has been the topic of several research reports. Keefe, Bruyette & Woods lowered Crescent Capital BDC from an "outperform" rating to a "market perform" rating and decreased their target price for the stock from $18.50 to $17.00 in a research note on Friday, May 16th. Wall Street Zen downgraded Crescent Capital BDC from a "hold" rating to a "sell" rating in a research note on Thursday, May 22nd. Raymond James dropped their price target on Crescent Capital BDC from $20.00 to $17.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. Finally, Wells Fargo & Company lowered their target price on Crescent Capital BDC from $16.00 to $15.00 and set an "equal weight" rating on the stock in a research note on Friday, May 16th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $17.60.
Read Our Latest Stock Report on CCAP
Crescent Capital BDC Price Performance
Shares of Crescent Capital BDC stock traded down $0.19 during trading on Thursday, reaching $15.33. The company's stock had a trading volume of 122,912 shares, compared to its average volume of 134,015. The company has a quick ratio of 1.26, a current ratio of 1.32 and a debt-to-equity ratio of 1.18. Crescent Capital BDC, Inc. has a 12-month low of $13.54 and a 12-month high of $20.19. The company has a market capitalization of $567.94 million, a P/E ratio of 7.72 and a beta of 0.63. The business has a 50 day moving average price of $15.89 and a 200-day moving average price of $17.93.
Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last issued its quarterly earnings data on Wednesday, May 14th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.52 by ($0.07). The firm had revenue of $42.13 million for the quarter, compared to analyst estimates of $45.08 million. Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. As a group, sell-side analysts anticipate that Crescent Capital BDC, Inc. will post 2.09 EPS for the current year.
Crescent Capital BDC Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Monday, June 30th will be issued a $0.42 dividend. The ex-dividend date is Monday, June 30th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 10.96%. Crescent Capital BDC's dividend payout ratio (DPR) is 125.37%.
Crescent Capital BDC Company Profile
(
Free Report)
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Featured Articles

Before you consider Crescent Capital BDC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.
While Crescent Capital BDC currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.